Evidence map›Paper›PMID 36196412›Full record

ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2022

Examination of the dose distribution of volumetric modulated arc radiotherapy using a high-definition multi-leaf collimator for breast cancer patients with irradiated regional lymph nodes.

Yoshitsugu Matsumoto, Etsuo Kunieda, Natsumi Futakami, Takeshi Akiba, Ryuta Nagao, Tsuyoshi Fukuzawa, Tomomi Katsumata, Toshihisa Kuroki, Tatsuya Mikami, Yasuhiro Okumura and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Comparison of helical and TomoDirect techniques with simultaneous integrated boost in early breast cancer patients.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yoshitsugu MatsumotoDepartment of Radiation Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Etsuo KuniedaDepartment of Radiation Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Natsumi FutakamiDepartment of Radiation Oncology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan.
Takeshi AkibaDepartment of Radiation Oncology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan.
Ryuta NagaoDepartment of Radiation Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Tsuyoshi FukuzawaDepartment of Radiation Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Tomomi KatsumataDepartment of Radiation Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Toshihisa KurokiDepartment of Radiation Oncology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan.
Tatsuya MikamiDepartment of Radiation Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Yasuhiro OkumuraRadiological Technology Department, Clinical Technology Division, Tokai University Hospital, Isehara, Kanagawa, Japan.
Kenji SoudaRadiological Technology Department, Clinical Technology Division, Tokai University Hospital, Isehara, Kanagawa, Japan.
Eride MutuDepartment of Radiation Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Akitomo SugawaraDepartment of Radiation Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Tokai University · JPTokai University Hachioji Hospital · JPTokai University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A high-definition multi-leaf collimator (HD-MLC) with 5- and 10-mm fine MLCs is useful for radiotherapy. However, it is difficult to irradiate the mammary gland and supraclavicular region using a HD-MLC because of the narrow field of volumetric modulated arc radiotherapy (VMAT). Therefore, we aimed to evaluate the dose distribution of the VMAT dose using a HD-MLC in 15 patients with left breast cancer undergoing postoperative irradiation of breast and regional lymph nodes, including the internal mammary node. Materials and methods: The following four plans were generated: three-arc VMAT using HD-MLC (HD-VMAT), two tangential arcs and one-arc VMAT using HD-MLC (tHD-VMAT), three-dimensional conformal radiotherapy (3DCRT) using HD-MLC, and two-arc VMAT using the Millennium 120-leaf MLC (M-VMAT). We assessed the doses to the target volume and organs at risk. Results: The target dose distributions were higher for HD-VMAT than 3DCRT. There were no significant differences in the heart mean dose (D Conclusions: In cases of the mammary gland and regional lymph node irradiation, including the internal mammary node in patients with left breast cancer, HD-VMAT was not inferior to M-VMAT and provided a better dose distribution to the target volume and organs at risk compared with 3DCRT and tHD-VMAT.

Indexed as

breast cancerhigh-definition multi-leaf collimatorMillennium 120-leaf MLCthree-dimensional conformal radiotherapyvolumetric modulated arc therapy

Identifiers

PMID36196412
PMCPMC9521697
OpenAlexW4284966822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.